ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.17
      -0.60%
      US Tech 100
      20,211.60
      -0.67%
      Dow Jones
      43,750.86
      -0.47%
      Brent Oil
      72.135
      -0.10%
      Bitcoin
      90,084.35
      3.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ocular Therapeutix Inc (OCUL)

      7. Ocular Therapeutix Inc (OCUL) News

      Ocular Therapeutix Inc

      Ocular Therapeutix Inc (OCUL)

      NASDAQ
      9.92
      -0.68
      (-6.42%)
      Closed November 14 4:00PM
      Delayed by 15 minutes
      9.92
      0.00
      ( 0.00% )
      Pre Market: 7:02AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      OCUL News

      Official News Only

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 27 2024
      OCUL (-6.42%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 23 2024
      OCUL (-6.42%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 23 2024
      OCUL (-6.42%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 21 2024
      OCUL (-6.42%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 07 2024
      OCUL (-6.42%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 07 2024
      OCUL (-6.42%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 07 2024
      OCUL (-6.42%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 01 2024
      OCUL (-6.42%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      July 26 2024
      OCUL (-6.42%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      July 26 2024
      OCUL (-6.42%)

      OCUL Discussion

      View Posts
      Whalatane Whalatane 4 weeks ago
      Scotiabank Initiates Coverage On Ocular Therapeutix with Sector Outperform Rating, Announces Price Target of $22

      Kiwi
      👍️0
      Whalatane Whalatane 1 month ago
      https://investors.ocutx.com/node/13236/pdf...trial enrolling ahead of schedule

      Kiwi
      👍️0
      Whalatane Whalatane 1 month ago
      As per the recent conference ...recruiting is going well and the speculation is that their trial will be fully enrolled ahead of schedule .
      Eyelea ...the drug they will compete with ...is still increasing sales

      Kiwi
      👍️0
      Whalatane Whalatane 4 months ago
      Anybody out there ? Nice day to have a position in OCUL
      Kiwi
      👍️0
      Whalatane Whalatane 7 months ago
      OCUL. P2 data 4/5/24
      REUTERS
      10:03 AM ET 04/06/2024
      April 6 (Reuters) - Ocular Therapeutix Inc (OCUL):
      * OCULAR THERAPEUTIX™ ANNOUNCES POSITIVE PHASE 2 PAXTRAVA™ GLAUCOMA DATA AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024 ANNUAL MEETING
      * OCULAR THERAPEUTIX INC (OCUL) - GENERALLY WELL TOLERATED WITH NO IMPACT ON CORNEAL HEALTH OBSERVED
      * OCULAR THERAPEUTIX INC (OCUL) - CLINICALLY MEANINGFUL MEAN IOP REDUCTION OF ABOUT 24-30% FROM BASELINE OBSERVED OVER SIX MONTHS Source text for Eikon: Further company coverage:

      Kiwi
      👍️0
      Monksdream Monksdream 8 months ago
      OCUL under $10
      👍️0
      Monksdream Monksdream 8 months ago
      OCUL 10Q due March 11
      👍️0
      glenn1919 glenn1919 11 months ago
      OCUL....................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
      👍️0
      trendzone trendzone 2 years ago
      Tard sells $6.00 call option at $0.15 at the close,apparently they were born yesterday.
      👍️0
      glenn1919 glenn1919 2 years ago
      OCUL..........................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
      👍️0
      trendzone trendzone 2 years ago
      Clueless fool sells $6.00 call option at $0.10 when they were just trading at $0.30,with the big rally going on in the stock today, what a total fool they are.
      👍️0
      cuggegrosse cuggegrosse 2 years ago
      I chose OCUL to invest in because the market conditions should not effect the PPS(much),plus I can sell covered calls and make some monthly cash,besides they have products that are in demand !!!!
      👍️ 1
      cuggegrosse cuggegrosse 2 years ago
      Yes I have noticed that
      👍️ 1
      Tzr250rg Tzr250rg 2 years ago
      Ask is super thin wont take much to move. GLTUA
      👍️0
      cuggegrosse cuggegrosse 2 years ago
      My eye doctor says Dextenza is a very good drug and he raccomends it !!!!!
      👍️ 1
      cuggegrosse cuggegrosse 2 years ago
      DEXTENZA is doing very,very well,great revs expected in 2023
      👍️ 1
      cuggegrosse cuggegrosse 2 years ago
      This company could go to $8.00 very eassy
      👍️ 1
      spotonge spotonge 2 years ago
      boys need to wake up
      👍️0
      biotechslayr biotechslayr 2 years ago
      Is anyone at all following OCUL into the end of the months binary? TKI data could be a game changer. Total TAM is ridiculous (look at REGN mcap!)
      👍️ 1
      oxnous oxnous 3 years ago
      OCUL --charting


      👍️0
      oxnous oxnous 3 years ago
      With the aging population, eye care is becoming an increasing concern. Dry eye, glaucoma, macular degeneration etc. will be expanding market sub sectors
      👍️0
      ClayTrader ClayTrader 4 years ago
      * * $OCUL Video Chart 04-29-2021 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      whytestocks whytestocks 4 years ago
      Just In: $OCUL Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

      Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Ter...

      In case you are interested OCUL - Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts
      👍️0
      whytestocks whytestocks 4 years ago
      Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

      OTX-CSI demonstrates improvement in signs and symptoms of Dry Eye Disease Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the ey...

      Got this from OCUL - Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
      👍️0
      TheFinalCD TheFinalCD 4 years ago
      OCUL 10.87 NEW HIGH OF DAY
      👍️0
      whytestocks whytestocks 4 years ago
      Just In: $OCUL Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

      Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...

      Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter
      👍️0
      now invest now invest 4 years ago
      Thus far OCUL is trading nicely!!
      👍️0
      ClayTrader ClayTrader 4 years ago
      * * $OCUL Video Chart 05-22-2020 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 03-04-2020 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      edwardport edwardport 5 years ago
      near term 10% projected increase in market price

      closed on 2/7/20 @ $5.21
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 02-07-2020 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 01-03-2020 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 11-29-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      TFMG TFMG 5 years ago
      OCUL - POSSIBLE 25% TREND MOVE ON THE DAILY

      Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

      SHORT INTEREST
      8.24M 07/15/19

      P/E Current
      -2.78

      P/E Ratio (with extraordinary items)
      -2.92

      Average Recommendation: OVERWEIGHT

      Average Target Price: 9.67

      👍️0
      tste9 tste9 5 years ago
      Great news! BUT, hoped for more volume price etc. wow
      GLA
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 07-26-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      whytestocks whytestocks 5 years ago
      News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

      Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a ...

      Got this from Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services
      👍️0
      smallbio smallbio 5 years ago

      Is DEXTENZA currently only targeting medicare patients, as there is no private insurance company will reimburse the cost?
      👍️0
      tste9 tste9 5 years ago
      What is up with this little piggy, lately! #&*#@*
      👍️0
      tste9 tste9 5 years ago
      Great news thanks for post. Do you know of any web site that posts OCUL sales per week. Thank you. GL
      👍️0
      whytestocks whytestocks 5 years ago
      News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

      Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and ...

      In case you are interested https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-commercial-launch-of-dextenza-x-8439742.html
      👍️0
      swingingRichard swingingRichard 5 years ago
      Shorted 10,000 shares. Looking good.
      👍️0
      tste9 tste9 5 years ago
      Shorts ease out as usual. criminal how shorts manipulate SP then just slither out unharmed. GLA
      👍️0
      tste9 tste9 5 years ago
      YEA BABY!
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 06-21-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      whytestocks whytestocks 5 years ago
      News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

      DEXTENZA ® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...

      Find out more https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-fda-approval-of-supplemental-new-drug-application-snda-for-dextenza-xae-0-4-dexamethasone-intracanalicular-insert-for-ophthalmic-use-for-the-treatment-of-ocular-inflammation-following-ophthalmic-surgery-8394606.html
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 06-11-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      Tzr250rg Tzr250rg 5 years ago
      low volume today
      👍️0
      whytestocks whytestocks 5 years ago
      News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®

      Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved t...

      Got this from https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-receipt-of-c-code-and-pass-through-payment-status-for-dextenza-xae--8261962.html
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $OCUL Video Chart 05-21-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0

      Your Recent History

      NASDAQ
      OCUL
      Ocular Therapeutix
      Delayed Upgrade Clock